Article Contents ::
- 1 The Brand Name GYNO-TERAZOL OVULES Has Generic Salt :: Terconazole
- 2 GYNO-TERAZOL OVULES Is From Company Ethnor Priced :: Rs. 50
- 3 GYNO-TERAZOL OVULES have Terconazole is comes under Sub class Anti Fungals of Main Class Anti Infectives
- 4 Main Medicine Class:: Anti Infectives Sub Medicine Class :: Anti Fungals
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name GYNO-TERAZOL OVULES Has Generic Salt :: Terconazole
GYNO-TERAZOL OVULES Is From Company Ethnor Priced :: Rs. 50
GYNO-TERAZOL OVULES have Terconazole is comes under Sub class Anti Fungals of Main Class Anti Infectives
Main Medicine Class:: Anti Infectives Sub Medicine Class :: Anti Fungals
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Drug Dose ::
Adult: Vag Insert 40 mg (0.8% cream) or 80 mg pessary once at bedtime for 3 nights or 20 mg (0.4% cream) once at bedtime for 7 nights.
Drug Precautions ::
Discontinue if irritation or flu-like symptoms develop. May damage latex or rubber contraceptives. Patients <18 yrs. Pregnancy. Drug Side Effects ::
Vulvovaginal burning, vulvar itching, dysmenorrhoea, genital, body and abdominal pain. Flu-like syndrome with headache, fever, chills and hypotension with doses >80 mg.
Pregnancy category ::
Drug Mode of Action ::
Terconazole disrupts ergosterol synthesis by binding to fungal cytochrome P450. It is active in vitro against Candida spp. and other fungi. It has some antibacterial activity in vitro but not against usual vag flora e.g, lactobacilli.
Drug Interactions ::
May decrease absorption of ciprofloxacin, ciclosporin, mycophenolate, tacrolimus and levothyroxine. Sevelamer should be given 3 hr before or 1 hr after taking other drugs to minimise potential pharmacokinetic interaction.